Research into more effective treatments for chronic myeloid leukemia is opening up all sorts of possibilities. Drugs are being combined, new drugs are being developed and there is even work involving a possible vaccine.

The outlook for people with chronic myeloid leukemia has improved by leaps and bounds in recent years. A number of medications are now keeping the disease under wraps.

Finding new uses for existing drugs has taken on new emphasis of late. With advanced technology making it easier to test for "new" benefits in existing drugs, medical researchers may have hit a home run with an old antibiotic.

For the first time, U.S. Food and Drug Administration officials have given the green light to an umbilical cord blood product that could be used in stem cell transplants for patients with blood cancer, or metabolic or immune disorders.

So you have to take a pill every day. It's saving your life, but doing anything every single day for the rest of your life is daunting. Recent research looked at which medications leukemia patients take more faithfully.

Genes are continuing to be the superheroes of treatment breakthroughs. A new study has discovered a gene linked to leukemia coming back in younger patients.

Teaming up with a partner makes any difficult task easier. When therapies team up even the difficult task of dealing with an incurable disease is made easier.

The Fourth American Association of Cancer Research ( AACR ) Conference on The Science of Cancer Health Disparities is demonstrating that different races live with and survive cancers at very different rates. Acute leukemia is no exception.

Acute leukemias occur rapidly and are often extremely difficult to treat. Researchers have found that an existing cardiovascular medication may offer new treatment options.

Researchers have had success in identifying genetic errors that lead to a number of different types of cancers. This hasn't been the case with blood cancers, though - until now.